L. Scarpace

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Lisa Scarpace, Lisa M. Scarpace, Lisa M Scarpace, L Scarpace, L. Scarpace
Publication record
83 papers · 18,404 citations · H-index 32

PAPERS

CLRM-10 ENHANCED PATIENT CARE FOR BRAIN METASTASIS PATIENTS UTILIZING A DEDICATED METASTASIS TUMOR BOARD
20230 citationsauthor #10
SAT587 Methylation-based Machine Learning Classifiers Discriminate Sellar Tumors By Lobe Origin Using Liquid Biopsy Or Surgical Specimens
20230 citationsauthor #11
Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors
202225 citationsauthor #8
INNV-33. THE IMPACT OF COVID-19 ON NEURO-ONCOLOGY CLINICAL TRIALS DURING WAVE 1 AND WAVE 2 AT A FRONTLINE DETROIT HEALTH CARE SYSTEM
20210 citationsauthor #6
INNV-25. PATIENT CENTERED MULTI-DISCIPLINARY NEURO-ONCOLOGIC CARE AS DIRECTED BY NEW PATIENT STAKEHOLDERS
20200 citationsauthor #3
INNV-14. UTILIZATION OF A PATIENT FAMILY ADVISORY COUNCIL TO ADVANCE PATIENT-CENTERED CARE OF BRAIN TUMOR PATIENTS
20200 citationsauthor #2
PATH-64. PROSPECTIVE, BLINDED PLASMA BASED ANALYSIS FOR DIAGNOSIS OF NEWLY DIAGNOSED GLIOMA
20190 citationsauthor #2
Adapting to Space Limitations During Prone Real-Time Magnetic Resonance Imaging-Guided Stereotaxic Laser Ablation: Technical Pearls.
20192 citationsauthor #2
Abstract LB-234: Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas
20190 citationsauthor #10
Pathogenic Germline Variants in 10,389 Adult Cancers.
2018695 citationsauthor #428
Erratum: Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment (Cancer Cell (2017) 32(1) (42–56.e6)(S1535610817302532)(10.1016/j.ccell.2017.06.003))
2018150 citationsauthor #6
Oncogenic Signaling Pathways in The Cancer Genome Atlas.
20182,523 citationsauthor #421
MR‐guided laser interstitial thermal therapy in the treatment of recurrent intracranial meningiomas
201821 citationsauthor #2
The Immune Landscape of Cancer.
20184,497 citationsauthor #421
TMIC-22. EXOSOMAL NON-CODING RNAS MEDIATE THE CROSS-TALK OF BRAIN METASTASIS CANCER STEM CELLS AND MICROGLIA
20180 citationsauthor #5
Fresh Brain Tissue Diagnostics Using Raman Spectroscopy in Humans
20181 citationsauthor #4
Comprehensive Characterization of Cancer Driver Genes and Mutations
20181,913 citationsauthor #425
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
2018747 citationsauthor #396
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context
2018229 citationsauthor #399
The safety of magnetic resonance imaging-guided laser interstitial thermal therapy for cerebral radiation necrosis
201836 citationsauthor #4
PATH-37. LIQUID BIOPSY FOR IDENTIFICATION OF NEWLY DIAGNOSED GLIOMA
20180 citationsauthor #2
TMIC-22. DECIPHERING GLIOMA INTRINSIC TRANSCRIPTIONAL SUBTYPES IDENTIFIES TUMOR EVOLUTION ASSOCIATES WITH CHANGES IN IMMUNE-MICROENVIRONMENT
20170 citationsauthor #5
Intraoperative Raman Spectroscopy.
201727 citationsauthor #4
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
20171,516 citationsauthor #6
Tumor evolution of glioma intrinsic gene expression subtype associates with immunological changes in the microenvironment
201658 citationsauthor #8
NIMG-52DYNAMIC CONTRAST ENHANCED MR ESTIMATION OF PHARMACOKINETIC PARAMETERS OF GLIOBLASTOMA MULTIFORME TUMORS: A COMPARISON STUDY FOR PERITUMORAL AND GLOBAL ARTERIAL INPUT FUNCTIONS USING MODEL SELECTION TECHNIQUE
20151 citationsauthor #6
Prediction of glioblastoma multiforme response to bevacizumab treatment using diffusion and perfusion imaging
20150 citationsauthor #3
MTR-19A MACROPHAGE-/MICROGLIAL-RICH TUMOR MICROENVIRONMENT MIMICS PRONEURAL TO MESENCHYMAL TRANSITION IN GLIOBLASTOMA
20150 citationsauthor #6
NIMG-50SURVIVAL RATE PREDICTION IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM), USING DYNAMIC CONTRAST ENHANCED MRI AND NESTED MODEL SELECTION TECHNIQUE (NMS).
20150 citationsauthor #9
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
20152,666 citationsauthor #282
Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients.
2015129 citationsauthor #14
Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution
2015378 citationsauthor #14
NIMG-53A FUZZY-BASED MODEL TO PREDICT THE SURVIVAL RATE OF PATIENTS WITH GIOBLASTOMA MLTIFORME TUMOR.
20151 citationsauthor #7
Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.
2014216 citationsauthor #5
Abstract 984: Alteration of the p53 pathway is associated with subclonal tumor progression in glioblastoma
20140 citationsauthor #12
THE P53 PATHWAY AND ANCESTRAL PROGENITORS ARE ASSOCIATED WITH TUMOR RECURRENCE IN GLIOBLASTOMA
20140 citationsauthor #15
GE-17ALTERATION OF THE p53 PATHWAY AND ANCESTRAL PROGENITORS ARE ASSOCIATED WITH TUMOR RECURRENCE IN GLIOBLASTOMA
20140 citationsauthor #13
GE-14TRANSCRIPTOMICPLASTICITYIS ASSOCIATED WITH THE TUMOR MICROENVIRONMENT IN GLIOBLASTOMA
20140 citationsauthor #5
GE-29EXPRESSION SUBCLASS PROFILE IN PSEUDOPROGRESSION AND TRUE PROGRESSION IN NEWLY DIAGNOSED GBM
20140 citationsauthor #6
Machine-Based Morphologic Analysis of Glioblastoma Using Whole-Slide Pathology Images Uncovers Clinically Relevant Molecular Correlates
2013106 citationsauthor #6
Tumor-Infiltrating Lymphocytes in Glioblastoma Are Associated with Specific Genomic Alterations and Related to Transcriptional Class
2013184 citationsauthor #8
MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set.
2013429 citationsauthor #8
5118 COMPARISON OF LOGAN PLOT ANALYSIS AND NESTED MODEL SELECTION TECHNIQUE FOR MR ESTIMATION OF DISTRIBUTION VOLUME IN HUMAN BRAIN TUMOR AT 3 TESLA
20130 citationsauthor #8
5200 MR Estimation of Permeability Parameters in Dynamic Contrast Enhanced Studies Using Model Averaging Technique and Nested Model Selection Method
20131 citationsauthor #6
Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers.
2013138 citationsauthor #5
Abstract B130: The intratumoral heterogeneity of glioblastoma suggests a pivotal role for clonal evolution.
20131 citationsauthor #12
NEURO/MEDICAL ONCOLOGY
20134 citationsauthor #369
Multi-modality discrimination of brain glioma grades using diffusion tensor and spectroscopic MRI
20130 citationsauthor #3
The Corpus Callosum Wallerian Degeneration in the Unilateral Brain Tumors: Evaluation with Diffusion Tensor Imaging (DTI).
201314 citationsauthor #6
AI-010. ACTIVATION OF THE PROTOTYPICAL SFK C-Src PROMOTES ANGIOGENESIS OF HUMAN GLIOBLASTOMA
20130 citationsauthor #104
Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
201321 citationsauthor #5
Voxel-based treatment prediction of glioblastoma multiform tumor using diffusion tensor imaging
20120 citationsauthor #3
LAB-IMMUNOLOGY RESEARCH
20120 citationsauthor #99
Prediction of Glioblastoma Multiform Response to Bevacizumab Treatment Using Multi-Parametric MRI
201224 citationsauthor #4
Model selection for DCE‐T1 studies in glioblastoma
201282 citationsauthor #7
Integrated morphologic analysis for the identification and characterization of disease subtypes
201295 citationsauthor #10
Correlation of immunohistologic and perfusion vascular parameters with MR contrast enhancement using image-guided biopsy specimens in gliomas.
201118 citationsauthor #5
Permeability Estimates in Histopathology-Proved Treatment-Induced Necrosis Using Perfusion CT: Can These Add to Other Perfusion Parameters in Differentiating from Recurrent/Progressive Tumors?
201143 citationsauthor #4
The role of the development of hypertension or proteinuria in predicting outcome with the use of bevacizumab for patients with glioblastoma multiforme (GBM).
201111 citationsauthor #3
In Vivo Correlation of Tumor Blood Volume and Permeability with Histologic and Molecular Angiogenic Markers in Gliomas
2011102 citationsauthor #4
Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors
201132 citationsauthor #3
Voxel based treatment prediction using diffusion anisotropy indices and spatial information in Glioblastoma Multiform tumor
20110 citationsauthor #3
Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.
2011109 citationsauthor #5
Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT?
201018 citationsauthor #4
Imaging response criteria for recurrent gliomas treated with bevacizumab: Role of diffusion weighted imaging as an imaging biomarker
2010106 citationsauthor #2
Predicting survival in glioblastomas using diffusion tensor imaging metrics
201070 citationsauthor #4
Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis
201028 citationsauthor #3
Angiogenesis and Invasion
20103 citationsauthor #91
Correlation of DTI Metrics with Proliferation Index and Survival Analysis in Glioblastomas
20090 citationsauthor #6
Quantitative Estimation of Permeability Surface-Area Product in Astroglial Brain Tumors Using Perfusion CT and Correlation with Histopathologic Grade
2008147 citationsauthor #3
Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features
2007127 citationsauthor #4
FIRST‐PASS PERFUSION COMPUTED TOMOGRAPHY: INITIAL EXPERIENCE IN DIFFERENTIATING RECURRENT BRAIN TUMORS FROM RADIATION EFFECTS AND RADIATION NECROSIS
200771 citationsauthor #2
Salvage Radiosurgery of Recurrent Glioblastoma Multiforme: Radiographic Tumor Control and Clinical Outcome
20071 citationsauthor #3
2112 Long-Term Results of Proton Beam Therapy for Surgically Inaccessible or Residual Meningiomas
20070 citationsauthor #2
Comparison of MRSI and Image Guided Histopathology in Treatment Naive and Treated Patients with Malignant Glioma
20041 citationsauthor #2
Associations among Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficients, and Image-Guided Histopathology with Special Attention to Radiation Necrosis
2004197 citationsauthor #2
Correlations between Magnetic Resonance Spectroscopy and Image-guided Histopathology, with Special Attention to Radiation Necrosis
2002227 citationsauthor #3
Correlation between Magnetic Resonance Spectroscopy Imaging and Image-guided Biopsies: Semiquantitative and Qualitative Histopathological Analyses of Patients with Untreated Glioma
2001176 citationsauthor #2
Feature space analysis: effects of MRI protocols
20000 citationsauthor #2
Reproducibility of MRI segmentation using a feature space method
19981 citationsauthor #3
The chemical nature of the microelectronics industry.
19862 citationsauthor #2
Pathology
19160 citationsauthor #103
Differentiating from Recurrent/Progressive to Other Perfusion Parameters in Necrosis Using Perfusion CT: Can These Add Histopathology-Proved Treatment-Induced Permeability Estimates in
year unknown0 citationsauthor #4

TIMELINE

1916 0 citations

1986 2 citations

1998 1 citations

2000 0 citations

2001 176 citations

2002 227 citations

2004 198 citations

2007 199 citations

2008 147 citations

2009 0 citations

2010 225 citations

2011 315 citations

2012 201 citations

2013 898 citations

2014 216 citations

2015 3,175 citations

2016 58 citations

2017 1,543 citations

2018 10,812 citations

2019 2 citations

2020 0 citations

2021 0 citations

2022 25 citations

2023 0 citations

Unknown 0 citations

COAUTHOR MAP

CONCEPT FOOTPRINT